Skip to main content
OpenTrials
Completed

NCT Number: NCT04000100

Neostigmine for Ultrasound Guided Supraclavicular Brachial Plexus Block

Patients were randomly allocated into Two equal study groups each contain (40) patients : Patients in Group A received supraclavicular block using 25mL of 0. 5% bupivacaine and 1 mL normal saline and patients in Group B received 25 mL 0. 5% bupivacaine and 1 mL neostigmine (0.5 mg).

The investigators found that neostigmine when used as an adjuvant to bupivacaine in ultrasound guided supraclavicular brachial plexus block has advantage over bupivacaine alone especially in the quality of sensory block and provide safe and effective post-operative analgesia in patients undergoing forearm surgeries

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Minya university hospital

Minya, 611111, Egypt

About this study

All patients were assessed with regards to:

Hemodynamics (heart rate, Bp) and oxygen saturation were recorded preoperatively just before the block as a baseline value, immediately after the block 5, 20, 30,40,45 , 60 minutes during the operative time and 1, 2, 4, 6, 9 and 12 hours after end of operation.

Onset time of sensory block, Onset time of motor block, Duration of sensory block, and Duration of motor block.

Pain assessment using a scoring system based on the visual analogue pain scale(VAS) measured at the following time intervals 0, 2, 4, 6, 9, 12 and 24 post operatively, time to first analgesic requirement (in hours) and total analgesic consumption was monitored in the two groups for 24 hours in ward.

The incidence of adverse effects whether related to the drugs used in the technique or related to the technique itself were recorded.

The results of this study found that demographic (age, sex, weight and ASA classification and surgical duration were statistically insignificant between the two groups.

Hemodynamics (HR and Bp) were statistically significant between the groups .They were lower in Neostigmine groups.

As regard onset of sensory and motor block were clinically and significantly earlier in group B than group A ( p < 0,05) and the same for duration of sensory and motor block were clinically and significantly longer in group B than in group A ( P < 0,05 ). Regarding Visual Analogue Pain Scale (VAS), while comparing the two groups, the differences were significant at 9 and 12 hours after surgery for the favor of the neostigmine groups . The time to first analgesic request was significantly longer in group B than group A.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA ( I-II)
  • Age: from ≥18 years
  • Sex: male or female
  • type of operation : Forearm Orthopedic surgeries
  • Type of anaesthesia : supraclavicular brachial plexus block
  • Duration of operation : 60-90 min

Exclusion criteria

  • Patient refusal for the procedure
  • Any bleeding tendency
  • Neurological deficits involving brachial plexus
  • Patients with allergy to local anesthetics
  • Local infection at the site of injection
  • Patients on any sedatives or antipsychotics
  • Body mass index >35.

Treatment and study plan

ultrasound- guided supraclavicular brachial plexus block

Procedure

Patient lie down supine with head turned 45 degrees to the contralateral side and ipsilateral arm adducted gently by the assistant and the shoulder kept down with flexed elbow.

After sterile preparation of the skin and the ultrasound probe (12 MHz probe) were used, the brachial plexus was visualized by placing the transducer in the sagittal plane in the supraclavicular fossa behind the middle-third of the clavicle. Two distinct appearances of the brachial plexus was seen at the supraclavicular region, it either appeared as 3 hypoechoic circles with hyperechoic outer rings or as a grape like cluster of 5 to 6 hypoechoic circles, located lateral and superior to the subclavian artery between the anterior and middle scalene muscles at the lower cervical region figure

Primary outcomes

  1. The onset of sensory blockade

    Time frame: Every 2 minutes for 30 minutes

    Onset time for sensory block was defined as the time interval between the end of local anesthetic administration untill complete sensory block by minutes

  2. The onset of motor blockade

    Time frame: Every 2 minutes for 30 minutes

    Onset time for motor block was defined as the time interval between the end of local anesthetic administration until complete motor block by minutes

  3. Duration of sensory blockade

    Time frame: Every 1 hour for 24 hours

    Duration of sensory block was defined as the time interval between the complete sensory block and complete resolution of anesthesia on all the nerves by hours

  4. Duration of motor blockade

    Time frame: Every 1 hour for 24 hours

    the time interval from complete motor block to complete recovery of motor function of hand and forearm by hours

Secondary outcomes

  1. Duration of analgesia (first request for analgesic)

    Time frame: Every 30 minutes for 4 hours then every 2 hours for 24 hours

    The time from local anesthetic administration to the patient's first request for analgesic medication by hours

  2. Visual analogue pain score

    Time frame: 2,4,6,8,12,16,20 and 24 hours postoperative

    Pain intensity was assessed using Visual analogue pain score. The Visual analogue pain score is consisted of a straight ,vertical 10-cm line; the bottom point represented "no pain"=(0 cm) and the top "the worst pain you could ever have =(10 cm)

Sponsors and collaborators

Lead sponsor

ABEER HASSANIN

Other

Registry information

Official study title

Effect OF Adding Neostigmine to Bupivacaine for Ultrasound Guided Supraclavicular Brachial Plexus Block in Forearm Surgeries

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jun 27, 2019
Registry last updated
Aug 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.